Steven lo's Net Worth

$12.1 Million

Estimate Recalculated Apr 12, 2024 06:01PM EST

Who is Steven lo?

Steven lo has an estimated net worth of $12.1 Million. This is based on reported shares across multiple companies, which include CORCEPT THERAPEUTICS INC, Zosano Pharma Corp, and PUMA BIOTECHNOLOGY, INC..

SEC CIK

Steven lo's CIK is 0001501959

Past Insider Trading and Trends

2015 was Steven lo's most active year for acquiring shares with 15 total transactions. Steven lo's most active month to acquire stocks was the month of October. 2015 was Steven lo's most active year for disposing of shares, totalling 5 transactions. Steven lo's most active month to dispose stocks was the month of December. 2010 saw Steven lo paying a total of $1,404,000.00 for 400,000 shares, this is the most they've acquired in one year. In 2015 Steven lo cashed out on 229,166 shares for a total of $754,285.16, their largest year based on trade value.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

CORCEPT THERAPEUTICS INC (CORT) Snapshot price: $22.36

SVP Oncology

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
∞
585.42K
$3.07
$1,796,008.83
585.42K
Nov 16
Form 4
—
0
$3.65
-$8,875.00
12.5K
Oct 26 - Nov 2
Form 4
-100.00%
-53.03K
$3.82
-$202,586.06
0
Oct 13
Form 4
-9.09%
-5.30K
$4.00
-$21,200.00
53.03K
Oct 7
Form 4
-46.15%
-50.00K
$3.76
-$188,000.00
58.33K
Oct 6
Form 4
∞
108.33K
$2.70
$292,499.10
108.33K
Sep 29
Form 4
—
0
—
—
0
Feb 18
Form 4
—
0
—
—
0
Nov 19
Form 4
—
0
—
—
0
Jan 30
Form 4
—
0
—
—
0
Oct 10
Form 4
—
0
—
—
0
Sep 24
Form 3
—
0
—
—
0
No matching records found

Zosano Pharma Corp No price found

Chief Executive Officer

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-3.25%
-442.00
$0.71
-$313.82
13.16K
Jun 6
Form 4
-4.88%
-23.63K
$0.21
-$4,965.29
460.71K
Mar 31
Form 4
+32.48%
118.75K
—
—
484.34K
Oct 15
Form 4
-3.47%
-13.16K
$0.81
-$10,592.19
365.59K
Jun 4
Form 4
+158.97%
232.5K
—
—
378.75K
Mar 30
Form 4
—
0
—
—
0
Mar 18
Form 4
∞
146.25K
—
—
146.25K
Jun 25
Form 4
—
0
—
—
0
Jun 3
Form 4
—
0
—
—
0
Oct 21
Form 3
—
0
—
—
0
No matching records found

PUMA BIOTECHNOLOGY, INC. (PBYI) Snapshot price: $5.05

Chief Commercial Officer

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-8.65%
-1.85K
$10.04
-$18,599.64
19.56K
Scheduled
Jul 22
Form 4
—
0
—
—
0
Feb 6
Form 4
-8.99%
-2.11K
$24.91
-$52,663.55
21.41K
Scheduled
Jan 22
Form 4
-7.25%
-1.84K
$51.85
-$95,360.06
23.52K
Scheduled
Jul 20
Form 4
—
0
—
—
0
Feb 11
Form 4
-6.83%
-1.86K
$92.85
-$172,515.30
25.36K
Scheduled
Jan 22
Form 4
-6.81%
-1.99K
$94.90
-$188,852.99
27.22K
Scheduled
Jul 20
Form 4
—
0
—
—
0
Feb 16
Form 4
-7.27%
-2.29K
$33.24
-$76,108.38
29.21K
Scheduled
Jan 20
Form 4
∞
31.5K
—
—
31.5K
Oct 14
Form 4
—
0
—
—
0
May 25
Form 4
—
0
—
—
0
Sep 8
Form 3
—
0
—
—
0
No matching records found

Vaxart, Inc. (VXRT) No price found

President, Chief Exec Officer

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
∞
250K
—
—
250K
Mar 18
Form 3
—
0
—
—
0
No matching records found